Novelix Pharmaceuticals share news and announcements
BSE: 536565Healthcare ServicesSmall Cap
Last close ₹59.54down ₹3.19 (5.09%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹62.73.
52-week range of traded prices to 23 Oct 2026
₹45.03Low, 23 Oct 2025₹92.00High, 16 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹170 Cr2,861st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 13 Aug 2026
- 46.7
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 13 Aug 2026
- 11.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 13 Aug 2026
- 8.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.09
- Volume, BSEVolume. Shares traded on the last trading day.
- 1,524
Novelix Pharmaceuticals routine notices
115 filed, newest first. Page 2 of 3.
Mar 2024
Jan 2024
31 Jan · Routine
13 Jan · Routine
2 Jan · Routine
Oct 2023
19 Oct · Routine
17 Oct · Routine
Sep 2023
29 Sep · Routine
Aug 2023
24 Aug · Routine
Jul 2023
15 Jul · Routine
Jun 2023
30 Jun · Routine
May 2023
1 May · Routine
Apr 2023
Mar 2023
29 Mar · Routine
Jan 2023
6 Jan · Routine
Dec 2022
29 Dec · Routine
Oct 2022
18 Oct · Routine
Sep 2022
30 Sep · Routine
Jul 2022
19 Jul · Routine
Jun 2022
29 Jun · Routine
Apr 2022
Mar 2022
28 Mar · Routine
Jan 2022
Dec 2021
29 Dec · Routine
Oct 2021
Sep 2021
27 Sep · Routine
Jul 2021
Jun 2021
27 Jun · Routine
Apr 2021
Mar 2021
27 Mar · Routine
Jan 2021
Dec 2020
Oct 2020
Sep 2020
29 Sep · Routine
Aug 2020
Jul 2020
Jun 2020
Apr 2020
Feb 2020
Jan 2020
Nov 2019
Oct 2019